Table 1 Projection of the future number (in millions) and percent (%) prevalence of US adults with diagnosed diabetes, by age group for selected years 2014–2060
From: Projection of the future diabetes burden in the United States through 2060
Population (Millions) | |||||
Age group (in years) | |||||
18–44 | 45–64 | 65–74 | > = 75 | Total | |
2014 | 2.86 | 10.27 | 5.51 | 3.67 | 22.31 |
(2.67, 3.07) | (9.79, 10.77) | (5.28, 5.75) | (3.46, 3.89) | (21.19, 23.48) | |
2020 | 3.84 | 12.1 | 8.01 | 5.32 | 29.27 |
(3.53, 4.21) | (11.54, 12.71) | (7.70, 8.34) | (5.07, 5.60) | (27.84, 30.86) | |
2030 | 5.01 | 13.67 | 10.92 | 10.11 | 39.71 |
(4.45, 5.68) | (12.72, 14.71) | (10.34, 11.57) | (9.58, 10.73) | (37.09, 42.69) | |
2040 | 5.32 | 16.42 | 11.22 | 14.89 | 47.86 |
(4.69, 6.08) | (15.11, 17.87) | (10.50, 12.00) | (14.00, 15.92) | (44.30, 51.87) | |
2050 | 5.51 | 18.94 | 12.86 | 16.99 | 54.3 |
(4.85, 6.30) | (17.38, 20.66) | (11.98, 13.81) | (15.88, 18.27) | (50.09, 59.06) | |
2060 | 5.75 | 19.71 | 15.69 | 19.48 | 60.63 |
(5.06, 6.58) | (18.07, 21.54) | (14.60, 16.88) | (18.14, 21.01) | (55.86, 66.01) | |
Prevalence (%) | |||||
Age group (in years) | |||||
18–44 | 45–64 | 65–74 | > = 75 | Total | |
2014 | 2.5 | 12.3 | 20.8 | 18.5 | 9.1 |
(2.3, 2.6) | (11.7, 12.9) | (19.9, 21.7) | (17.4, 19.6) | (8.6, 9.5) | |
2020 | 3.2 | 14.4 | 24.1 | 22.7 | 11.2 |
(2.9, 3.5) | (13.7, 15.1) | (23.2, 25.1) | (21.7, 23.9) | (10.6, 11.8) | |
2030 | 3.9 | 16.5 | 27.7 | 28.6 | 13.9 |
(3.5, 4.4) | (15.4, 17.8) | (26.2, 29.3) | (27.1, 30.3) | (13.0, 15.0) | |
2040 | 4.1 | 17.9 | 30.4 | 31.8 | 15.7 |
(3.6, 4.7) | (16.5, 19.5) | (28.5, 32.5) | (29.9, 34.0) | (14.5, 17.0) | |
2050 | 4.1 | 19.1 | 32.3 | 33.9 | 16.8 |
(3.6, 4.7) | (17.6, 20.9) | (30.1, 34.7) | (31.7, 36.4) | (15.5, 18.3) | |
2060 | 4.2 | 19.6 | 33.8 | 36 | 17.9 |
(3.7, 4.8) | (17.9, 21.4) | (31.5, 36.4) | (33.5, 38.8) | (16.5, 19.5) | |